Noradrenaline-induced increases in calcium and tension in skeletal muscle conductance and resistance arteries from rats with post-infarction heart failure

European Journal of Pharmacology
Simon TrautnerMajid Sheykhzade

Abstract

We tested the hypothesis that arterial reactivity to noradrenaline is augmented in congestive heart failure (CHF), which could contribute to the deleterious changes in peripheral vascular resistance and compliance in this condition. From male Wistar rats with post-infarction CHF and sham-operated rats, skeletal muscle conductance and resistance arteries (mean lumen diameters: 514 and 186 microm) were isolated and mounted on wire myographs, and wall tension was recorded in response to cumulative application of acetylcholine and noradrenaline to the vessel segments. In a subset of experiments, wall tension and cytosolic free calcium ion concentration [Ca(2+)](i) were recorded simultaneously during noradrenaline application, using wire myography and the FURA-2 technique. No significant differences were found in the arterial baseline levels of [Ca(2+)](i) or tension between CHF and sham rats. In the resistance arteries of CHF rats, the noradrenaline-induced increases in [Ca(2+)](i) were significantly enhanced (P=0.003). Despite the augmented [Ca(2+)](i) levels, the tension responses to noradrenaline were unaltered in these arteries. In the conductance arteries, there were no significant differences in noradrenaline-induced [Ca(2+)]...Continue Reading

References

Apr 1, 1979·Circulation Research·M A PfefferE Braunwald
Nov 1, 1975·Progress in Cardiovascular Diseases·R ZelisD T Mason
Apr 1, 1992·Pflügers Archiv : European journal of physiology·P E JensenC Aalkjaer
Nov 1, 1990·Journal of Cardiovascular Pharmacology·C Forster, P W Armstrong
Feb 1, 1990·Cell Calcium·M W RoeB Herman
Oct 1, 1990·Physiological Reviews·M J Mulvany, C Aalkjaer
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
May 1, 1982·Progress in Cardiovascular Diseases·R Zelis, S F Flaim
Aug 1, 1993·Journal of the American College of Cardiology·J R TeerlinkJ P Clozel
Jun 1, 1997·Journal of Cardiovascular Pharmacology·F R StassenJ G De Mey
Jun 5, 1998·The American Journal of Physiology·N StephensA M Heagerty
Mar 12, 1999·Journal of Molecular and Cellular Cardiology·J V Mombouli, P M Vanhoutte
May 18, 1999·Cardiovascular Research·M J Mulvany
Jun 18, 1999·Journal of Molecular and Cellular Cardiology·Y IshigaiT Shibano
Mar 11, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·K P PatelP K Carmines
Mar 17, 2001·British Journal of Pharmacology·M Sheykhzade, N C Berg Nyborg
Dec 26, 2001·Hypertension·G F MitchellM A Pfeffer
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·David S GoldsteinIrwin J Kopin
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Dierk H Endemann, Ernesto L Schiffrin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.